IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM PAR
Total 13F shares
9,537,334
Share change
+656,035
Total reported value
$35,003,022
Put/Call ratio
45%
Price per share
$3.67
Number of holders
51
Value change
+$2,431,945
Number of buys
30
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q4 2020

As of 31 Dec 2020, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,537,334 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Artal Group S.A., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, HOLLENCREST CAPITAL MANAGEMENT, and 683 Capital Management, LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.